These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 10516853)

  • 1. Prolactin involvement in breast cancer.
    Vonderhaar BK
    Endocr Relat Cancer; 1999 Sep; 6(3):389-404. PubMed ID: 10516853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolactin: the forgotten hormone of human breast cancer.
    Vonderhaar BK
    Pharmacol Ther; 1998 Aug; 79(2):169-78. PubMed ID: 9749881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of prolactin in mammary carcinoma.
    Clevenger CV; Furth PA; Hankinson SE; Schuler LA
    Endocr Rev; 2003 Feb; 24(1):1-27. PubMed ID: 12588805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolactin as an autocrine/paracrine factor in breast tissue.
    Clevenger CV; Plank TL
    J Mammary Gland Biol Neoplasia; 1997 Jan; 2(1):59-68. PubMed ID: 10887520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolactin as an autocrine/paracrine growth factor in human cancer.
    Ben-Jonathan N; Liby K; McFarland M; Zinger M
    Trends Endocrinol Metab; 2002 Aug; 13(6):245-50. PubMed ID: 12128285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Should prolactin be reconsidered as a therapeutic target in human breast cancer?
    Goffin V; Touraine P; Pichard C; Bernichtein S; Kelly PA
    Mol Cell Endocrinol; 1999 May; 151(1-2):79-87. PubMed ID: 10411322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of prolactin in breast cancer: redefining the molecular targets.
    Llovera M; Touraine P; Kelly PA; Goffin V
    Exp Gerontol; 2000 Feb; 35(1):41-51. PubMed ID: 10705038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice.
    Bole-Feysot C; Goffin V; Edery M; Binart N; Kelly PA
    Endocr Rev; 1998 Jun; 19(3):225-68. PubMed ID: 9626554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of the prolactin receptor but not the growth hormone receptor is important for induction of mammary tumors in transgenic mice.
    Wennbo H; Gebre-Medhin M; Gritli-Linde A; Ohlsson C; Isaksson OG; Törnell J
    J Clin Invest; 1997 Dec; 100(11):2744-51. PubMed ID: 9389738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolactin: the new biology of an old hormone.
    Goffin V; Binart N; Touraine P; Kelly PA
    Annu Rev Physiol; 2002; 64():47-67. PubMed ID: 11826263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endogenous human prolactin and not exogenous human prolactin induces estrogen receptor alpha and prolactin receptor expression and increases estrogen responsiveness in breast cancer cells.
    Gutzman JH; Miller KK; Schuler LA
    J Steroid Biochem Mol Biol; 2004 Jan; 88(1):69-77. PubMed ID: 15026085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolactin as a mitogen in mammary cells.
    Das R; Vonderhaar BK
    J Mammary Gland Biol Neoplasia; 1997 Jan; 2(1):29-39. PubMed ID: 10887517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolactin overexpression by MDA-MB-435 human breast cancer cells accelerates tumor growth.
    Liby K; Neltner B; Mohamet L; Menchen L; Ben-Jonathan N
    Breast Cancer Res Treat; 2003 May; 79(2):241-52. PubMed ID: 12825859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolactin expression and secretion by human breast glandular and adipose tissue explants.
    Zinger M; McFarland M; Ben-Jonathan N
    J Clin Endocrinol Metab; 2003 Feb; 88(2):689-96. PubMed ID: 12574200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolactin and the prolactin receptor: new targets of an old hormone.
    Harris J; Stanford PM; Oakes SR; Ormandy CJ
    Ann Med; 2004; 36(6):414-25. PubMed ID: 15513293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reevaluation of the proposed autocrine proliferative function of prolactin in breast cancer.
    Nitze LM; Galsgaard ED; Din N; Lund VL; Rasmussen BB; Berchtold MW; Christensen L; Panina S
    Breast Cancer Res Treat; 2013 Nov; 142(1):31-44. PubMed ID: 24146212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local insulin-like growth factor-II mediates prolactin-induced mammary gland development.
    Hovey RC; Harris J; Hadsell DL; Lee AV; Ormandy CJ; Vonderhaar BK
    Mol Endocrinol; 2003 Mar; 17(3):460-71. PubMed ID: 12554791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A favorable role of prolactin in human breast cancer reveals novel pathway-based gene signatures indicative of tumor differentiation and favorable patient outcome.
    Hachim IY; Shams A; Lebrun JJ; Ali S
    Hum Pathol; 2016 Jul; 53():142-52. PubMed ID: 26980025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological and clinical aspects of prolactin receptors (PRL-R) in human breast cancer.
    Bonneterre J; Peyrat JP; Beuscart R; Demaille A
    J Steroid Biochem Mol Biol; 1990 Dec; 37(6):977-81. PubMed ID: 2285609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New concepts in prolactin biology.
    Bernichtein S; Touraine P; Goffin V
    J Endocrinol; 2010 Jul; 206(1):1-11. PubMed ID: 20371569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.